Maria M. Piggin

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology.

Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology.

Journal: Frontiers in pharmacology

Published: November 10, 2025

Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.

Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.

Journal: Vaccine

Published: March 27, 2025

What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?

What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?

Journal: Annals of hematology

Published: February 24, 2025

Methodological study protocol for The European Atlas of clinical trials in cancer and haematology.

Methodological study protocol for The European Atlas of clinical trials in cancer and haematology.

Journal: Frontiers in pharmacology

Published: January 10, 2025

The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective.

The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 27, 2022

Addressing Inequality of Access to Biologics: What Is Your Role? A Patient (Advocate)'s Perspective on Biosimilars.

Addressing Inequality of Access to Biologics: What Is Your Role? A Patient (Advocate)'s Perspective on Biosimilars.

Journal: HemaSphere

Published: March 17, 2022

The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life.

The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life.

Journal: European journal of haematology

Published: March 14, 2022

The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic.

The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic.

Journal: Epidemics

Published: January 31, 2022

Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study.

Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study.

Journal: Wellcome open research

Published: January 18, 2022

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research.

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research.

Journal: Frontiers in psychiatry

Published: June 18, 2021

Fair Pricing of Innovative Medicines: An EHA Position Paper.

Fair Pricing of Innovative Medicines: An EHA Position Paper.

Journal: HemaSphere

Published: August 19, 2020

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper.

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper.

Journal: HemaSphere

Published: July 29, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026